Journal articles on the topic '0941'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic '0941.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Fouda, A. S., M. A. Ismail, A. S. Abousalem, and G. Y. Elewady. "Experimental and theoretical studies on corrosion inhibition of 4-amidinophenyl-2,2′-bifuran and its analogues in acidic media." RSC Adv. 7, no. 73 (2017): 46414–30. http://dx.doi.org/10.1039/c7ra08092a.
Full textThriveni*, M. C., Raju Mondal, G. Thanavendan, G. Ravikumar, and B. T. Sreenivasa. "Characterization of Mulberry Genetic Resources for Multiple Traits." Indian Journal of Botany 1, no. 2 (October 10, 2021): 8–15. http://dx.doi.org/10.35940/ijb.b2004.101221.
Full textYang, Hongqin, Yanjun Ma, Hongjie Zhang, and Junyi Ma. "PI3K/mTOR Dual Inhibitor Pictilisib Stably Binds to Site I of Human Serum Albumin as Observed by Computer Simulation, Multispectroscopic, and Microscopic Studies." Molecules 27, no. 16 (August 9, 2022): 5071. http://dx.doi.org/10.3390/molecules27165071.
Full textLoRusso, Patricia, Geoffrey Shapiro, Shuchi Sumant Pandya, Eunice Lee Kwak, Cheryl Jones, Marcia Belvin, Luna C. Musib, et al. "A first-in-human phase Ib study to evaluate the MEK inhibitor GDC-0973, combined with the pan-PI3K inhibitor GDC-0941, in patients with advanced solid tumors." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 2566. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.2566.
Full textMa, Xiaoju Max, Changchun Du, Laura Sun, Xiaoyan Shi, Lori Friedman, David Dornan, and Allen J. Ebens. "PI3K Signaling Pathway Activation Predicts Class I PI3K Inhibitor GDC-0941 Sensitivity in AML." Blood 114, no. 22 (November 20, 2009): 1057. http://dx.doi.org/10.1182/blood.v114.22.1057.1057.
Full textDe, Pradip, Yuliang Sun, Lori Friedman, Nandini Dey, and Brian Leyland-Jones. "Effect of pan-PI3K and HER2 blockade on antitumor activity in preclinical models of breast cancer resistance to trastuzumab therapy." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e13570-e13570. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13570.
Full textJin, Linhua, Yoko Tabe, Yixin Zhou, Takashi Miida, Michael Andreeff, and Marina Konopleva. "Efficacy and Mechanisms of Apoptosis Induction by Simultaneous Inhibition of PI3K with GDC-0941 and Blockade of Bcl-2 (ABT-737) or FLT3 (Sorafenib) In AML Cells In the Hypoxic Bone Marrow Microenvironment." Blood 116, no. 21 (November 19, 2010): 777. http://dx.doi.org/10.1182/blood.v116.21.777.777.
Full textSarker, D., R. Kristeleit, K. E. Mazina, J. A. Ware, Y. Yan, M. Dresser, M. K. Derynck, and J. De-Bono. "A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 3538. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.3538.
Full textKikuchi, Hugh, Eunice Amofa, Maeve Mcenery, Steve Arthur Schey, Karthik Ramasamy, Farzin Farzaneh, and Yolanda Calle. "Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics." Cancers 15, no. 2 (January 11, 2023): 462. http://dx.doi.org/10.3390/cancers15020462.
Full textDail, Monique, Jason Wong, Jessica Lawrence, Daniel O'Connor, Joy Nakitandwe, Shann-Ching Chen, Keiko Akagi, et al. "Preclinical Testing Of a PI3K Inhibitor In T Lineage Leukemia: Target Validation and Notch1/Myc Down-Regulation In Drug Resistant Clones." Blood 122, no. 21 (November 15, 2013): 2677. http://dx.doi.org/10.1182/blood.v122.21.2677.2677.
Full textTsumura, Yoshinori, Yu Tsushima, Azusa Tamura, Hirotsugu Kato, and Tsunefumi Kobayashi. "Disruptions in hepatic glucose metabolism are involved in the diminished efficacy after chronic treatment with glucokinase activator." PLOS ONE 17, no. 3 (March 21, 2022): e0265761. http://dx.doi.org/10.1371/journal.pone.0265761.
Full textLi, Xiaodong, Yuanyue Zhang, Williams Walana, Feng Zhao, Fang Li, and Fuwen Luo. "GDC-0941 and CXCL8 (3-72) K11R/G31P combination therapy confers enhanced efficacy against breast cancer." Future Oncology 16, no. 14 (May 2020): 911–21. http://dx.doi.org/10.2217/fon-2020-0035.
Full textTabe, Yoko, Linhua Jin, Takashi Miida, Michael Andreeff, and Marina Konopleva. "Growth-Inhibitory Effects of a Class I PI3K Inhibitor GDC-0941 Are Modulated by Hypoxia-Induced mTOR Pathway Activation in Mantle Cell Lymphoma." Blood 118, no. 21 (November 18, 2011): 1424. http://dx.doi.org/10.1182/blood.v118.21.1424.1424.
Full textThriveni, Mallegowdanakoppalu C., Sampathkumar Deepa, Ganesan Thanavendan, G. Ravikumar, and B. T. Sreenivasa. "Characterization and Evaluation of Mulberry Genetic Resources for the Identification of Promising Accessions." Indian Journal of Plant Genetic Resources 36, no. 01 (December 9, 2023): 85–95. http://dx.doi.org/10.61949/0976-1926.2023.v36i01.12.
Full textMunugalavadla, Veerendra, Leanne Berry, Changchun Du, Sanjeev Mariathasan, Dion Slaga, Laura Sun, Marta Chesi, Peter Leif Bergsagel, and Allen J. Ebens. "The PI3K Inhibitor GDC-0941 Synergizes with Standard of Care Therapies to Induce Growth Inhibition and Apoptosis of Multiple Myeloma Cells." Blood 114, no. 22 (November 20, 2009): 3788. http://dx.doi.org/10.1182/blood.v114.22.3788.3788.
Full textWagner, A. J., D. H. Von Hoff, P. M. LoRusso, R. Tibes, K. E. Mazina, J. A. Ware, Y. Yan, M. K. Derynck, and G. D. Demetri. "A first-in-human phase I study to evaluate the pan-PI3K inhibitor GDC-0941 administered QD or BID in patients with advanced solid tumors." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 3501. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.3501.
Full textIyengar, Sunil, Andrew J. Clear, Andrew Owen, Lenushka Maharaj, Janet Matthews, Maria Calaminici, Rebecca Auer, et al. "PI3K Inhibition with GDC-0941 Has Greater Efficacy Compared to p110δ-Selective Inhibition with CAL-101 in Mantle Cell Lymphoma and May Be Particularly Advantageous in Multiply Relapsed Patients." Blood 118, no. 21 (November 18, 2011): 1654. http://dx.doi.org/10.1182/blood.v118.21.1654.1654.
Full textChoi, Jae Hyeog, Ki Hyang Kim, Kug Hwan Roh, Hana Jung, Su Kil Seo, Il Whan Choi, Sung Su Yea, and SaeGwang Park. "Combination therapy of a PI3K p110α-isoform-selective inhibitor and anti-HER2/neu antibody enhances the anti-tumor immunity in breast cancer mouse model." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 204.9. http://dx.doi.org/10.4049/jimmunol.198.supp.204.9.
Full textMaski, K. P., F. Pizza, A. Colclasure, E. Steinhart, E. Little, C. Diniz Behn, S. Vandi, E. Antelmi, G. Plazzi, and T. Scammell. "0941 Defining Disrupted Nighttime Sleep in Pediatric Narcolepsy." Sleep 43, Supplement_1 (April 2020): A357—A358. http://dx.doi.org/10.1093/sleep/zsaa056.937.
Full textAuge, Oliver, and Adelina Wallnöfer. "Rezension von: Adelina Wallnöfer: Die politische Repräsentation des gemeinen Mannes in Tirol. Die Gerichte und ihre Vertreter auf den Landtagen vor 1500." Zeitschrift für Württembergische Landesgeschichte 78 (January 17, 2022): 441–42. http://dx.doi.org/10.53458/zwlg.v78i.1481.
Full textIWASE, Toshinori, Takako MORIKAWA, Hideo FUKUDA, Kiyosuke SASAKI, and Masafumi YOSHITAKE. "Production of Acetic Esters by Williopsis beijerinckii IFO 0941." JOURNAL OF THE BREWING SOCIETY OF JAPAN 90, no. 4 (1995): 307–12. http://dx.doi.org/10.6013/jbrewsocjapan1988.90.307.
Full textMakieieva, N., A. Penkov, R. Marabyan, M. Kholodova, and I. Vasheva. "PO-0941 The Causes Of Psychosomatic Disorders In Children." Archives of Disease in Childhood 99, Suppl 2 (October 2014): A558.2—A558. http://dx.doi.org/10.1136/archdischild-2014-307384.1562.
Full textRobar, J., J. Allan, R. L. Macdonald, R. Rutledge, T. Joseph, J. Clancey, and K. Moran. "PO-0941: 3D printed bolus for chestwall radiation therapy." Radiotherapy and Oncology 119 (April 2016): S456—S457. http://dx.doi.org/10.1016/s0167-8140(16)32191-0.
Full textAkutagawa, Jon, Monique Dail, Lori S. Friedman, Kevin M. Shannon, Deepak Sampath, and Benjamin S. Braun. "The PI3K Inhibitor GDC-0941 Attenuates Disease in a KrasG12D Mouse Model of CMML and JMML." Blood 120, no. 21 (November 16, 2012): 2862. http://dx.doi.org/10.1182/blood.v120.21.2862.2862.
Full textEbens, Allen J., Leanne Berry, Yung-Hsiang Chen, Gauri Deshmukh, Jake Drummond, Changchun Du, Michael Eby, et al. "A Selective PIM Kinase Inhibitor Is Highly Active In Multiple Myeloma: The Biology of Single Agent and PI3K/AKT/mTOR Combination Activity." Blood 116, no. 21 (November 19, 2010): 3001. http://dx.doi.org/10.1182/blood.v116.21.3001.3001.
Full textFriedman, L., M. Belvin, L. Berry, P. Haverty, K. Hoeflich, M. Lackner, D. Sampath, J. Wallin, and B. Yauch. "142 GDC-0941 PI3K inhibitor activity in preclinical lung cancer models." European Journal of Cancer Supplements 8, no. 7 (November 2010): 51. http://dx.doi.org/10.1016/s1359-6349(10)71847-4.
Full textLam, Nhi, Monica Singh, and Alejandra Lastra. "0941 Sleep Apnea Testing in Hospitalized Patients: Are Patients Following Up?" SLEEP 46, Supplement_1 (May 1, 2023): A415. http://dx.doi.org/10.1093/sleep/zsad077.0941.
Full textChen, Haifeng, Mingming Cheng, Pengcheng Gao, Xiangzhong Zhang, Ganggang Li, Liting Wang, Long Qin, and Hongrui Li. "GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway." Bioengineered 13, no. 4 (April 1, 2022): 10944–55. http://dx.doi.org/10.1080/21655979.2022.2066758.
Full textKikuchi, Hugh, Amofa Eunice, Maeve McEnery, Farzin Farzaneh, Stephen A. Schey, and Yolanda Calle. "Inhibition Of PI3K Classia Kinases Using GDC0941 Overcomes Protection Of Multiple Myeloma Cells In The Bone Marrow Microenvironment." Blood 122, no. 21 (November 15, 2013): 3169. http://dx.doi.org/10.1182/blood.v122.21.3169.3169.
Full textFan, Xiu Cai, Hai Sheng Sun, Ying Zhang, Jian Fu Jiang, Min Li, and Chong Huai Liu. "Genetic Diversity of Vitis davidii Accessions Revealed Using Microsatellite and Sequence-related Amplified Polymorphism Markers." HortScience 53, no. 3 (March 2018): 283–87. http://dx.doi.org/10.21273/hortsci12506-17.
Full textleung, W. K., E. P. P. Pang, S. K. T. Cheung, W. H. Mui, B. B. W. Wo, H. Liu, J. C. W. Siang, et al. "PD-0941 Feasibility of prostatic calcifications tracking using 4D transperineal ultrasound (TPUS)." Radiotherapy and Oncology 161 (August 2021): S783—S784. http://dx.doi.org/10.1016/s0167-8140(21)07220-0.
Full textMANABE, Masashi, and Shunji HIROKAWA. "0941 Assessment of kinematics of knee prosthesis after TKA about flexion motion." Proceedings of the Bioengineering Conference Annual Meeting of BED/JSME 2009.22 (2010): 353. http://dx.doi.org/10.1299/jsmebio.2009.22.353.
Full textKAMEO, Yoshitaka, Taiji ADACHI, and Masaki HOJO. "0941 Theoretical Analysis of Interstitial Fluid Flow in Trabecula as Poroelastic Materials." Proceedings of the JSME annual meeting 2007.5 (2007): 183–84. http://dx.doi.org/10.1299/jsmemecjo.2007.5.0_183.
Full textTrojani, V., A. Botti, M. Grehn, B. Balgobind, A. Savini, E. Pruvot, J. Verhoeff, M. Iori, and O. Blanck. "OC-0941 STereotactic Arrhythmia Radioablation in Europe: STOPSTORM Consortium Treatment Planning Benchmark." Radiotherapy and Oncology 182 (May 2023): S788—S790. http://dx.doi.org/10.1016/s0167-8140(23)08767-4.
Full textAl-Negheimish, Abdulaziz, Abdulrahman Alhozaimy, Raja Rizwan Hussain, Rajeh Al-Zaid, J. K. Singh, and D. D. N. Singh. "Role of Manganese Sulfide Inclusions in Steel Rebar in the Formation and Breakdown of Passive Films in Concrete Pore Solutions." CORROSION 70, no. 1 (January 2014): 74–86. http://dx.doi.org/10.5006/0941.
Full textEdge, Sarah D., Isaline Renard, Emily Pyne, Chun Li, Hannah Moody, Rajarshi Roy, Andrew W. Beavis, et al. "PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma." British Journal of Radiology 94, no. 1119 (March 1, 2021): 20201191. http://dx.doi.org/10.1259/bjr.20201191.
Full textGupta, Madhulika. "0941 Limb Movements in Sleep [LMS] and PTSD-related Physical Symptoms: Preliminary Observations." SLEEP 47, Supplement_1 (April 20, 2024): A404. http://dx.doi.org/10.1093/sleep/zsae067.0941.
Full textNováková, Jana, Pavel Talacko, Petr Novák, and Karel Vališ. "The MEK-ERK-MST1 Axis Potentiates the Activation of the Extrinsic Apoptotic Pathway during GDC-0941 Treatment in Jurkat T Cells." Cells 8, no. 2 (February 21, 2019): 191. http://dx.doi.org/10.3390/cells8020191.
Full textLi, Haifu, Agnieszka Wozniak, Karel Van Den Bossche, Thomas Van Looy, Jasmien Wellens, Marguerite Stas, Giuseppe Floris, et al. "Efficacy of the phosphoinositol 3 kinase (PI3K) inhibitor GDC-0941 in patient- and cell-line-derived xenografts of dedifferentiated liposarcoma (DDLPS)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e13528-e13528. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13528.
Full textHuang, Tannie, Jon Akutagawa, Inbal Epstein, Charisa Cottonham, Maricel Quirindongo-Crespo, and Benjamin S. Braun. "Inhibition of Akt Signaling Alleviates MDS/MPN Driven By KrasD12 or Nf1 Loss." Blood 126, no. 23 (December 3, 2015): 360. http://dx.doi.org/10.1182/blood.v126.23.360.360.
Full textShi, L., X. Gao, X. Li, N. Jiang, F. Luo, C. Gu, M. Chen, H. Cheng, and P. Liu. "Ellagic Acid Enhances the Efficacy of PI3K Inhibitor GDC-0941 in Breast Cancer Cells." Current Molecular Medicine 15, no. 5 (July 10, 2015): 478–86. http://dx.doi.org/10.2174/1566524015666150505161046.
Full textPersoon, L. C. G. G., A. Sanizadeh, B. De Ruiter, S. Nijsten, F. Verhaegen, and E. G. C. Troost. "PO-0941: Adaptive radiotherapy based on integrated transit planar dosimetry for lung cancer patients." Radiotherapy and Oncology 115 (April 2015): S492—S493. http://dx.doi.org/10.1016/s0167-8140(15)40933-8.
Full textFloyd, R., N. McDermott, A. Meunier, and L. Marignol. "PO-1061: Radiosensitisation properties of PI3K/AKT inhibitor GDC-0941 in prostate cancer cells." Radiotherapy and Oncology 115 (April 2015): S572. http://dx.doi.org/10.1016/s0167-8140(15)41053-9.
Full textVan den Bosch, M., B. Vanneste, R. Voncken, and L. Lutgens. "PO-0941: Verifying the treatment planning system in individualized HDR brachytherapy of cervical cancer." Radiotherapy and Oncology 123 (May 2017): S521. http://dx.doi.org/10.1016/s0167-8140(17)31378-6.
Full textKirkegård, Jakob, Jennifer L. Lund, Frank Viborg Mortensen, and Deirdre Cronin‐Fenton. "Author's Reply to: “Design flaws in statins and pancreatic cancer research” (IJC‐19‐0941)." International Journal of Cancer 145, no. 5 (May 12, 2019): 1450–51. http://dx.doi.org/10.1002/ijc.32349.
Full textAl Mamun, Md Zia Uddin, Md Mamunur Rashid, Mohajira Begum, Maesha Musarrat, Md Ariful Haq, and Rahima Akter Sathee. "Appraisal of Vitamin D3 Concentration in Dietary Supplement Marketed in Bangladesh using HPLC." Oriental Journal Of Chemistry 38, no. 6 (December 30, 2022): 1440–44. http://dx.doi.org/10.13005/ojc/380615.
Full textEhrhardt, Michael, Rogerio B. Craveiro, Martin I. Holst, Torsten Pietsch, and Dagmar Dilloo. "The PI3K inhibitor GDC-0941 displays promisingin vitro and in vivoefficacy for targeted medulloblastoma therapy." Oncotarget 6, no. 2 (December 6, 2014): 802–13. http://dx.doi.org/10.18632/oncotarget.2742.
Full textMarampon, F., G. L. Gravina, M. E. La Verghetta, M. Cerasani, S. Parente, M. Mancini, D. Di Genova, L. Ferella, M. Reale, and E. Di Cesare. "PO-0941: MEK/ERK inhibition radiosensitizes rhabdomyosarcoma cells by downregulating growth and DNA repair signals." Radiotherapy and Oncology 111 (2014): S123—S124. http://dx.doi.org/10.1016/s0167-8140(15)31059-8.
Full textSun, Laura, Leanne Berry, Changchun Du, Xiaoju Max Ma, Lily Shi, Bruno C. Medeiros, and Allen J. Ebens. "The PI3K Inhibitor GDC-0941 Induces Growth Arrest and Apoptosis of Acute Myeloid Leukemia Cells." Blood 114, no. 22 (November 20, 2009): 3787. http://dx.doi.org/10.1182/blood.v114.22.3787.3787.
Full textDolde, K., S. Schneider, A. Pfaffenberger, and A. Hoffmann. "PO-0941: 3D motion validation with clinically used cine-MRI and an MR-LINAC phantom." Radiotherapy and Oncology 127 (April 2018): S511—S512. http://dx.doi.org/10.1016/s0167-8140(18)31251-9.
Full text